LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Abstract
Objective: A recently published study showed the safety and efficacy of LSD-assisted psychotherapy in patients with anxiety associated with life-threatening diseases. Participants of this study were included in a prospective follow-up. Method: 12 months after finishing LSD psychotherapy, 10 participants were tested for anxiety (STAI) and participated in a semi-structured interview. A Qualitative Content Analysis (QCA) was carried out on the interviews to elaborate about LSD effects and lasting psychological changes. Results: None of the participants reported lasting adverse reactions. The significant benefits as measured with the STAI were sustained over a 12-month period. In the QCA participants consistently reported insightful, cathartic and interpersonal experiences, accompanied by a reduction in anxiety (77.8%) and a rise in quality of life (66.7%). Evaluations of subjective experiences suggest facilitated access to emotions, confrontation of previously unknown anxieties, worries, resources and intense emotional peak experiences à la Maslow as major psychological working mechanisms. The experiences created led to a restructuring of the person’s emotional trust, situational understanding, habits and world view. Conclusions: LSD administered in a medically supervised psychotherapeutic setting can be safe and generate lasting benefits in patients with a life-threatening disease. Explanatory models for the therapeutic effects of LSD warrant further study.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“all stated to have profited from the treatment and felt more relaxed and patient (Gasser et al., 2015).”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Gasser et al., 2015
In the citing paper
“Seven of these participants were less anxious (about death)”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Gasser et al., 2015
In the citing paper
“Positive psychological changes included increased relaxation, equanimity, self-assurance, and mental strength.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Gasser et al., 2015
In the citing paper
“and six reported improved quality of life.”
From Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review (2022) · cites this paper as Gasser et al., 2015
In the citing paper
“In the patient group, these findings are consistent with previous research showing that “complete” mystical experiences are rare and not necessary for therapeutic effect (Gasser et al., 2015; Schmid et al., 2021), although other studies do show correlations between MEQ30 scores and therapeutic effects in PAT for depression and anxiety disorders (Davis et al., 2021; Griffiths et al., 2016; Holze et”
From Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response (2024) · cites this paper as Gasser et al., 2015
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
(1970) · Cited by 24,983
The varieties of religious experience: A study in human nature.
James, W. (1902) · doi:10.1037/10004-000 · Cited by 5,204
Mapping the structural core of human cerebral cortex
Hagmann, P., Cammoun, L., Gigandet, X., Meuli, R., Honey, C. J., Wedeen, V. J., & Sporns, O. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060159 · Cited by 4,173
Learning from Strangers: The Art and Method of Qualitative Interview Studies
Adler, P. A., Adler, P., & Weiss, R. S. (1995) · Contemporary Sociology · doi:10.2307/2076552 · Cited by 3,586
Gusnard, D. A., Akbudak, E., Shulman, G. L., & Raichle, M. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071043098 · Cited by 2,997
Maxwell, J. (2009) · The SAGE Handbook of Applied Social Research Methods · doi:10.4135/9781483348858.n7 · Cited by 1,734 · cited 1×
“To explore subjective experiences and elements of the therapeutic process of the participants in more detail, qualitative semi-structured interviews were conducted to gain a more holistic understanding from a client-centred perspective (Maxwell, 2009; Weiss, 1995).”
BackgroundGriffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 4×
“Some individuals report deeply touching, ‘religious–mystical’ and perspective-altering experiences on LSD/psilocybin (Griffiths et al., 2006; McGlothlin et al., 1967).”
BackgroundInfluentialCarhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.116 · Cited by 1,206 · cited 3×
“In line with another recent investigation (Grob et al., 2011), the present pilot study included patients suffering from existential anxiety induced by a life-threatening disease.”
MethodResultNeural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Carhart-Harris, R. L., Erritzoe, D., Williams, T., Stone, J. M., Reed, L. J., Colasanti, A., Tyacke, R. J., Leech, R., Malizia, A. L., Murphy, K., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119598109 · Cited by 1,172 · cited 3×
“Psilocybin-induced reduction of blood flow in DMN regions alters the integrity of the DNM and thereby leads to ‘unconstrained cognition’ and changes in the experience of the self (Carhart-Harris et al., 2012a).”
BackgroundPsilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018 · cited 2×
“Indolealkylamine hallucinogens such as LSD and psilocybin have high affinity to 5-HT receptors (Nichols, 2004; Pierce and Peroutka, 1989) with the 5-HT2A receptor as the primary site of action and significant modulation by 5-HT2C and 5-HT1A receptors (Fiorella et al., 1995; Vollenweider et al., 1998).”
BackgroundReligions, Values, and Peak-Experiences
Wulff, D. M. (1965) · The Journal of Higher Education · doi:10.1080/00221546.1965.11774448 · Cited by 984
Religions, Values, and Peak-Experiences
Jones, R. G., & Maslow, A. H. (1965) · Journal for the Scientific Study of Religion · doi:10.2307/1384286 · Cited by 946
Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
Griffiths, R. R., Johnson, M. W., Richards, W. A., Richards, B. D., McCann, U., & Jesse, R. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2358-5 · Cited by 932
MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111420188 · Cited by 895
Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0000000000000113 · Cited by 750 · cited 8×
“Details of recruitment are described elsewhere (Gasser et al., 2014).”
BackgroundResultInfluentialSelf-citationThe neurobiology of psychedelic drugs: implications for the treatment of mood disorders
Vollenweider, F. X., & Kometer, M. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2884 · Cited by 723 · cited 3×
“Repeat administration leads to rapid desensitization, but it appears to be possible that the effects of increased BDNF on neuronal and synaptic formation and functioning contribute to the sustained psychological effects of some hallucinogens (Vollenweider and Kometer 2010).”
BackgroundInfluentialThe default-mode, ego-functions and free-energy: a neurobiological account of Freudian ideas
Carhart-Harris, R. L., & Friston, K. J. (2010) · Brain · doi:10.1093/brain/awq010 · Cited by 574
Vaidya, V. A., Marek, G. J., Aghajanian, G. K., & Duman, R. S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02785.1997 · Cited by 479
The pharmacology of lysergic acid diethylamide: A review
Passie, T., Halpern, J. H., Stichtenoth, D. O., Emrich, H. M., & Hintzen, A. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2008.00059.x · Cited by 455
Self-citationVollenweider, F. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00246-1 · Cited by 444 · cited 2×
“However, some of these reductions in brain activity are not congruent with earlier findings (e.g. Vollenweider et al., 1997).”
ResultFacial emotion processing in major depression: a systematic review of neuroimaging findings
Stuhrmann, A., Suslow, T., & Dannlowski, U. (2011) · Biology of Mood & Anxiety Disorders · doi:10.1186/2045-5380-1-10 · Cited by 440 · cited 3×
“Patients may regain mental flexibility as a result of treatment with LSD, which has been found to be reduced in depressive and anxiety disorders (Stuhrmann et al., 2011).”
BackgroundMultiple receptors contribute to the behavioral effects of indoleamine hallucinogens
Halberstadt, A. L., & Geyer, M. A. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.017 · Cited by 411
A systems model of altered consciousness: integrating natural and drug-induced psychoses
Vollenweider, F. X., & Geyer, M. A. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00646-3 · Cited by 343
Martı́n-Ruiz, R., Puig, M. V., Celada, P., Shapiro, D. A., Roth, B. L., Mengod, G., & Artigas, F. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-24-09856.2001 · Cited by 339
Hariri, A. R., Drabant, E. M., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.005 · Cited by 338
Vollenweider, F. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00108-0 · Cited by 305 · cited 2×
“, 2009) and humans (Vollenweider et al., 1999).”
BackgroundLYSERGIC ACID DIETHYLAMIDE: SIDE EFFECTS AND COMPLICATIONS
COHEN, S. (1960) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196001000-00005 · Cited by 287
Die Praxis der qualitativen Inhaltsanalyse
Mayring, P. (2005) · Cited by 277
Response of cluster headache to psilocybin and LSD
Sewell, R. A., Halpern, J. H., & Pope, H. G. (2006) · Neurology · doi:10.1212/01.wnl.0000219761.05466.43 · Cited by 259
Carhart-Harris, R. L., Leech, R., Williams, T. M., Erritzoe, D., Abbasi, N., Bargiotas, T., Hobden, P., Sharp, D. J., Evans, J., Feilding, A., et al. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.103309 · Cited by 237
Béïque, J.-C., Imad, M., Mladenovic, L., Gingrich, J. A., & Andrade, R. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700436104 · Cited by 229 · cited 1×
“Experimental results by Béïque et al. (2007) suggest that 5-HT2A activation directly enhances the activity of neuronal networks in the prefrontal cortex, with some subpopulations of 5-HT2A-activated pyramidal cells playing a significant role (Halberstadt and Geyer, 2011).”
ResultPuig, M. V. (2003) · Cerebral Cortex · doi:10.1093/cercor/13.8.870 · Cited by 222
The experimental use of psychedelic (LSD) psychotherapy.
Pahnke, W. N. (1970) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1970.03170240060010 · Cited by 220 · cited 1×
“Studies in the past have demonstrated more treatment effects for individuals who had psychedelic peak experiences, but those without them have also found significantly bettered (Pahnke et al., 1970; Richards et al., 1977).”
BackgroundGouzoulis-Mayfrank, E. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00089-x · Cited by 219 · cited 1×
“Neurometabolic and cerebral blood flow studies with hallucinogens in humans showed partially incongruent results (e.g. Carhart-Harris et al., 2012a; Gouzoulis-Mayfrank et al., 1999; Vollenweider et al., 1997).”
LSD-Assisted Psychotherapy in Patients with Terminal Cancer
Grof, S., Goodman, L. E., Richards, W. A., & Kurland, A. A. (2017) · International Pharmacopsychiatry · doi:10.1159/000467984 · Cited by 209
Psychopathology and pathophysiology of the self in depression-Neuropsychiatric hypothesis
Northoff, G. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.012 · Cited by 209 · cited 2×
“…experience, loosening of ego functions combined with pronounced self-referential processing of significant (intellectual/emotional) content, patients may gain a new perspective on themselves and a reduction of ruminations and ego-centredness (Leuner, 1967; Northoff, 2007; Pizzagalli, 2011).”
BackgroundLessons from the Peak-Experiences
MASLOW, A. H. (1962) · Journal of Humanistic Psychology · doi:10.1177/002216786200200102 · Cited by 206
Plants of the Gods: Origins of Hallucinogenic Use
Brenan, J. P. M., Schultes, R. E., & Hofmann, A. (1980) · Kew Bulletin · doi:10.2307/4110029 · Cited by 153
Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex
Pierce, P. A., & Peroutka, S. J. (1989) · Psychopharmacology · doi:10.1007/bf00443425 · Cited by 152
The psychedelic mystical experience in the human encounter with death
Pahnke, W. N. (1969) · Harvard Theological Review · doi:10.1017/s0017816000027577 · Cited by 147
Generic aspects of complexity in brain imaging data and other biological systems
Bullmore, E. T., Barnes, A., Bassett, D. S., Fornito, A., Kitzbichler, M. G., Meunier, D., & Suckling, J. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.05.032 · Cited by 145
Fiorella, D. J., Rabin, R. A., & Winter, J. C. (1995) · Psychopharmacology · doi:10.1007/bf02246074 · Cited by 137
The Use of LSD in Psychotherapy and Alcoholism
Blaine, G. B. (1968) · Psychosomatic Medicine · doi:10.1097/00006842-196807000-00014 · Cited by 135
The neural correlates of consciousness: an analysis of cognitive skill learning
The American Association for Research into Nervous and Mental Diseases, & Raichle, M. E. (1998) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1998.0341 · Cited by 130
Modulation by Estrogen-Receptor Directed Drugs of 5-Hydroxytryptamine-2A Receptors in Rat Brain
Cyr, M., Landry, M., & Paolo, T. D. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00085-3 · Cited by 116
Long Lasting Effects of LSD on Normals
McGlothlin, W. (1967) · Archives of General Psychiatry · doi:10.1001/archpsyc.1967.01730290009002 · Cited by 116
The role of neurotrophins in major depressive disorder
Jiang, C., & Salton, S. (2013) · Translational Neuroscience · doi:10.2478/s13380-013-0103-8 · Cited by 113
Leuner, H. (1962) · Monographien aus dem Gesamtgebiete der Neurologie und Psychiatrie · doi:10.1007/978-3-642-86258-8 · Cited by 112
Acute Adverse Reactions to Lsd in Clinical and Experimental use in the United Kingdom
Malleson, N. (1971) · British Journal of Psychiatry · doi:10.1192/bjp.118.543.229 · Cited by 111 · cited 3×
“This finding is congruent with surveys on LSD-assisted therapy, which have reported adverse events (psychotiform reactions, suicides etc.) in numbers comparable with psychotherapy without LSD (Cohen, 1960; Gasser, 1996; Malleson, 1971).”
BackgroundResultVazquez-Borsetti, P., Cortes, R., & Artigas, F. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn204 · Cited by 103
Attenuation of anticipation: A therapeutic use of lysergic acid diethylamide
Kast, E. (1967) · The Psychiatric Quarterly · doi:10.1007/bf01575629 · Cited by 94
The Peak Experience Variable in DPT-Assisted Psychotherapy with Cancer Patients
Richards, W. A., Rhead, J. C., Dileo, F. B., Yensen, R., & Kurland, A. A. (1977) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1977.10472020 · Cited by 94
Schamanismus und archaische Ekstasetechnik
Éliade, M. (1975) · Cited by 87
The Use of LSD in Psychotherapy and Alcoholism
Cohen, S. (1967) · Psychosomatics · doi:10.1016/s0033-3182(67)71930-1 · Cited by 83
Winter, J. C., Eckler, J. R., & Rabin, R. A. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1636-2 · Cited by 83
Hallucinations: Synchronisation of thalamocortical γ oscillations underconstrained by sensory input
Behrendt, R. (2003) · Consciousness and Cognition · doi:10.1016/s1053-8100(03)00017-5 · Cited by 78
Michael, L., Schkeryantz, J., & Burris, T. (2005) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557054553767 · Cited by 65
Mescaline, LSD, Psilocybin, and Personality Change a Review†
Unger, S. M. (1963) · Psychiatry · doi:10.1080/00332747.1963.11023344 · Cited by 60
LSD in the Supportive Care of the Terminally Ill Cancer Patient
Kurland, A. A. (1985) · Journal of Psychoactive Drugs · doi:10.1080/02791072.1985.10524332 · Cited by 58
The effects of psychedelic (LSD) therapy on values, personality, and behavior.
Savage, C., Fadiman, J., Mogar, R. E., & Allen, M. H. (1966) · PubMed · Cited by 33
The Nature of the LSD Experience
TKRKILL, J. (1962) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-196211000-00006 · Cited by 28
The role of BDNF and memory in major depressive disorder.
Adlam, J., & Zaman, R. (2013) · PubMed · Cited by 14
Research works printed but not linked: 11
- Adlam J, 2013, Psychiatr Danub, 2013, S368
- Diesch M, 2014, LSD: Rückkehr in die klinische Forschung
- Gasser P, 1996, Schweiz Arch Neurol Psych, 147, 59
- Grof S, 1975, Realms of the Human Unconscious
- Grof S, 1980, LSD Psychotherapy
- Hintzen A, 2010, The pharmacology of LSD
- Kirchner K, 2010, LSD-supported psychotherapy: effects on daily life and longterm changes
- Leuner H, 1981, Halluzinogene
- Meert TF, 1996, Serotonin in antipsychotic treatment, 109
- Savage C, 1966, Int J Neuropsychiatry, 2, 241
- Schweizerische Krebsliga, 2005, Schlussbericht Bestandesaufnahme psychosoziale Onkologie in der Schweiz
Cited by
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00974 · Cited by 808
Serotonin and brain function: a tale of two receptors
Carhart-Harris, R., & Nutt, D. (2017) · Journal of Psychopharmacology · doi:10.1177/0269881117725915 · Cited by 739
“…is increasing evidence that anxiety can be significantly reduced for a prolonged period after a therapeutically mediated psychedelic drug experience (Gasser et al., 2014, 2015; Griffiths et al., 2016; Grob et al., 2011) – for a discussion of this apparent paradox see (CarhartHarris et al., 2016c).”
BackgroundPsychedelic drugs: neurobiology and potential for treatment of psychiatric disorders
Vollenweider, F. X., & Preller, K. H. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0367-2 · Cited by 570
Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R. (2017) · Journal of Humanistic Psychology · doi:10.1177/0022167817709585 · Cited by 589
Metadata
- Authors
- Gasser, P., Kirchner, K., & Passie, T.
- Affiliations
- Medical Office for Psychiatry and Psychotherapy, Solothurn, Switzerland
- Psychologist MSc, Dietikon, Switzerland
- Harvard University (US)
- ORCID
- Passie, Torsten
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2014-11-11
- Volume
- 29
- Issue
- 1
- Pages
- 57-68
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2164276826
- Cited by
- 456
- References
- 65
- Citations by year
- 2026: 35 · 2025: 39 · 2024: 63 · 2023: 65 · 2022: 58 · 2021: 44 · 2020: 42 · 2019: 28 · 2018: 24 · 2017: 33 · 2016: 20 · 2015: 4
- FWCI
- 22.43
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- British Association for Psychopharmacology
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- anxiety, life-threatening illness, terminal illness, subjective experience, emotional catharsis, insight, quality of life, long-term outcomes, therapeutic mechanisms, emotional trust
- MeSH terms
- Adult, Anxiety Disorders, Double-Blind Method, Emotions, Female, Follow-Up Studies, Humans, Lysergic Acid Diethylamide, Male, Middle Aged, Neoplasms, Psychotherapy, Quality of Life, Treatment Outcome, Qualitative Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.